Whatisvalue,,,,,It appears as though you have not viewed the stockholder's meeting video or you have viewed it and opted to reject some of mgt's business plan.
Ed Marshall has stated that he doesn't believe that the company needs to expand much from its present size. They will most likely remain an R&d concern choosing to partner with large international concerns that own many hospitals. The company would sell the machines to the partner who then would be solely responsible for dissemination of the equipment, training, and utilization.
The key to this plan working is in the efficacy of the process. If the third level of testing and the beta test confirms the present level of confidence in the Ozone process, a contract will be signed with a hospital partner and a small number of machines (50-100) will be sold to them for operational use. When all are satisfied that the machine/process has been refined, a larger scale manufacturing and partnering agreements can be made.
This is a very manageable plan that will be driven by the successful results of the process. Since the company reverts into an order taker after the contract is signed, I don't see any need for a high powered, highly paid CEO. Just what is there to negotiate? The price of the machines will be established by the company and, with no competition, pricing becomes solely a company driven determination.
Ed has put together a team and a simple but compelling business plan that will be a success. I have invested in this company with that in mind. If and when this company needs more managerial talent, I have every confidence that Ed will find it just as he has done for the technical and medical elements of this business.
AI
